Clinical Trials Directory

Trials / Completed

CompletedNCT06295003

Impact of COVID-19 Pandemic on Headache Evaluations in the Pediatric Emergency Department

Status
Completed
Phase
Study type
Observational
Enrollment
700 (actual)
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
Sex
All
Age
2 Years – 18 Years
Healthy volunteers

Summary

Background: To evaluate the impact of COVID-19 on evaluations in the pediatric emergency department (ED) because of headache as main symptom. Methods: Number and clinical features of patients evaluated in the pediatric ED of a single site in Milan,Italy, were collected between January 2017 and January 2022. The impact of COVID-19 on evaluation rates was quantified by using the incidence rate ratio (IRR) and 95% confidence intervals (CI) between the pandemic (March 2020 to January 2022) and the prepandemic period (January 2017 to February 2020).

Conditions

Timeline

Start date
2022-04-30
Primary completion
2022-05-30
Completion
2022-05-30
First posted
2024-03-06
Last updated
2024-03-06

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06295003. Inclusion in this directory is not an endorsement.

Impact of COVID-19 Pandemic on Headache Evaluations in the Pediatric Emergency Department (NCT06295003) · Clinical Trials Directory